Data updated: Mar 10, 2026
TOLAZAMIDE
TOLAZAMIDE
Approved 1984-10-03
10
Indications
--
Phase 3 Trials
41
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1984-10-03
- Routes
- ORAL
- Dosage Forms
- TABLET
Companies
WATSON LABS Sun Pharma PAR PHARM USL PHARMA INTERPHARM CHARTWELL RX DURAMED PHARMS BARR COSETTE SUPERPHARM Teva NATCO
Active Ingredient: TOLAZAMIDE
Website: ↗
TOLAZAMIDE Approval History
Loading approval history...
What TOLAZAMIDE Treats
10 FDA approvalsOriginally approved for its first indication in 1984 . Covers 10 distinct patient populations.
- Other (10)
Other
(10 approvals)- • Approved indication (Oct 1984)
- • Approved indication (Jan 1986)
- • Approved indication (Jan 1986)
- • Approved indication (Jan 1986)
- • Approved indication (Jan 1986)
- • Approved indication (Mar 1986)
- • Approved indication (Jun 1986)
- • Approved indication (Nov 1986)
- • Approved indication (Jul 1987)
- • Approved indication (Dec 1987)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
TOLAZAMIDE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.